← Back to all earnings calls

Sutro Biopharma, Inc. Q3 FY2023 Earnings Call

Sutro Biopharma, Inc. (STRO)

Earnings Call FY2023 Q3 Call date: 2023-11-13 Concluded

Share

Quarter scorecard

Revenue

$16.92M

-32.7% YoY

Diluted EPS

$-8.10

Net income

-$49.28M

Documents & deck